The contract includes the drugs hydromorphone, a painkiller; cisatracurium, a skeletal muscle relaxant given before general anesthesia; Zosyn, a penicillin antibiotic; cefepime, a bacterial infection antibiotic; Dobutamine, a blood pressure drug; ondansetron, which is used to prevent nausea and vomiting; dopamine, a blood pressure drug; and heparin, which is used to prevent blood clots.
The stockpile is purchasing the drugs as part of HHS’ Strategic National Stockpile 2.0 plan to restructure and resupply the stockpile for any future COVID-19 waves. HHS said it plans to have 90 days of the most critical supplies in the stockpile this fall.
The stockpile previously awarded Fresenius Kabi $35 million to supply drugs and Baxter Healthcare $29.9 million, according to Bloomberg Law.
More articles on pharmacy:
FDA issues warning over TikTok ‘Benadryl challenge’
J&J says its COVID-19 vaccine spurred immune response in early study
Military personnel make up lion’s share of Operation Warp Speed leaders
